Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01307969
Other study ID # 164/2006
Secondary ID
Status Completed
Phase Phase 1
First received February 16, 2011
Last updated March 2, 2011
Start date February 2007
Est. completion date June 2007

Study information

Verified date February 2011
Source University of Campinas, Brazil
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

This blinded cross-over study aim to evaluate the efficacy of liposome-encapsulated ropivacaine formulation for dental anesthesia.


Description:

This blinded cross-over study aim to evaluate the efficacy of liposome-encapsulated 0, 5% ropivacaine for dental anesthesia after maxillary infiltration.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date June 2007
Est. primary completion date May 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 44 Years
Eligibility Inclusion Criteria:

- Healthy

Exclusion Criteria:

- Volunteers were free from cardiac, hepatic, renal, pulmonary, neurological, gastrointestinal and haematological diseases, psychiatric disorders and allergy to local anesthetics

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research


Related Conditions & MeSH terms

  • Underdosing of Local Anesthetics, Initial Encounter

Intervention

Drug:
Ropivacaine
1,8 mL of the local anesthetic formulations were injected at the apex of the maxillary right canine.

Locations

Country Name City State
Brazil Piracicaba Dental School Piracicaba São Paulo

Sponsors (2)

Lead Sponsor Collaborator
University of Campinas, Brazil Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary After anesthetic injection the pulpal response was assessed by an electrical pulp tester. 100 minutes No
Secondary Duration of soft tissue anesthesia was measured as the time from beginning to end of lip and gingival numbness. 240 minutes No